PATENTS
-
Title: PCT/EP2019/051157. Targeted interventions directed at reducing the levels of circulating succinate in a subject, and kits and method for determining effectiveness of said interventions. WO2019141780.
Inventors:Sonia Fernández-Veledo; Joan Vendrell; Carolina Serena; Victoria Ceperuelo-Mallafré; Enrique Calvo.
Patent owner: URV, IISPV, CIBERDEM.
Priority Countries: Europe.
Countries to which it has been extended: USA, Europe, India, Japan, Mexico, China; Australia, Canada.
Companies exploiting it: SUCCIPRO SL
Registration date: 2019
-
Title: EP1938254. Succinate as a biomarker for selecting a bariatric surgical procedure and for predicting type 2 diabetes mission after bariatric surgery. WO2021001303.
Inventors:Sonia Fernández-Veledo; Joan Vendrell; Victoria Ceperuelo-Mallafré; Nuria Vilarrasa; Gemma Llauradó.
Patent owner: URV, IISPV, CIBERDEM.
Priority Countries: Europe.
Registration date: 2019
-
Title: EP17382615.7. Methods for improving the cell therapy efficacy with mesenchymal stem cell populations. WO2019053295.
Inventors: Sonia Fernández-Veledo; Joan Vendrell; Carolina Serena; Antonio Zorzano.
Patent owner: URV, IISPV, CIBERDEM.
Priority Countries: Europe.
Registration Date: 2017
-
Title: Use of BPI protein for the treatment of disorders of the metabolism and cardiovascular disorders.
Inventors: Mellitus SL (Joan Vendrell Ortega).
Registratiion Date: 2007
-
Title: Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease.
Inventors: Mellitus SL (Joan Vendrell Ortega).
Registration Date: 2005
-
Title: Use of soluble CD14 for treatment of diseases.
Inventors: Mellitus SL (Joan Vendrell Ortega).
Registration Date: 2004